Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q3 2025 to Q4 2025
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 4
- Est. +$3.00M
- Added
- 27
- Est. +$21.8M
- Reduced
- 11
- Est. −$7.78M
- Sold out
- 4
- Est. −$9.20M
Portfolio value went from $103.8M to $113.3M (+$9.44M (+9.1%)); positions from 43 to 43 (0).
All Q4 2025 holdingsAll Q3 2025 holdings
In the shares, value and % of portfolio columns, the top figure is Q4 2025 and the gray one below is Q3 2025. For stocks that split between the two quarters, Q3 2025 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| NKTXNkarta, Inc. | AddedHistory | 40,70239,452 | +1,250+3.2% | $75.3K$81.7K | +$2.31K | 0.1%0.1% | −0.01 |
| CTMXCytomX Therapeutics, Inc. | AddedHistory | 18,69918,109 | +590+3.3% | $79.7K$57.8K | +$2.51K | 0.1%0.1% | +0.01 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Added– | 2,0211,991 | +30+1.5% | $223.0K$222.0K | +$3.31K | 0.2%0.2% | −0.02 |
| PMPhilip Morris International Inc. | AddedHistory | 1,4371,424 | +13+0.9% | $230.0K$231.0K | +$2.08K | 0.2%0.2% | −0.02 |
| iShares Tr464288372 | Added– | 3,9683,905 | +63+1.6% | $244.0K$239.0K | +$3.87K | 0.2%0.2% | −0.01 |
| iShares Tips Bond ETF464287176 | Added– | 2,2282,211 | +17+0.8% | $245.0K$246.0K | +$1.87K | 0.2%0.2% | −0.02 |
| iShares Tr464288513 | Added– | 3,2903,229 | +61+1.9% | $265.0K$262.0K | +$4.91K | 0.2%0.3% | −0.02 |
| REGNRegeneron Pharmaceuticals, Inc. | AddedHistory | 427412 | +15+3.6% | $329.4K$231.8K | +$11.6K | 0.3%0.2% | +0.07 |
| ProShares Tr74347R842 | Added– | 7,9777,945 | +32+0.4% | $375.1K$368.3K | +$1.50K | 0.3%0.4% | −0.02 |
| MDTMedtronic plc | AddedHistory | 4,2804,145 | +135+3.3% | $411.1K$394.7K | +$13.0K | 0.4%0.4% | −0.02 |
| ABTAbbott Laboratories | AddedHistory | 3,7563,012 | +744+24.7% | $470.6K$403.5K | +$93.2K | 0.4%0.4% | +0.03 |
| PFEPfizer Inc | AddedHistory | 19,10412,578 | +6,526+51.9% | $475.7K$320.5K | +$162.5K | 0.4%0.3% | +0.11 |
| UNHUnitedHealth Group Inc | AddedHistory | 1,4521,130 | +322+28.5% | $479.2K$390.0K | +$106.3K | 0.4%0.4% | +0.05 |
| INCYIncyte Corp | AddedHistory | 5,1983,744 | +1,454+38.8% | $513.4K$317.5K | +$143.6K | 0.5%0.3% | +0.15 |
| EWEdwards Lifesciences Corp | AddedHistory | 6,1134,492 | +1,621+36.1% | $521.1K$349.3K | +$138.2K | 0.5%0.3% | +0.12 |
| DEDeere & Co | AddedHistory | 1,1331,129 | +4+0.4% | $528.0K$516.0K | +$1.86K | 0.5%0.5% | −0.03 |
| JPMJPMorgan Chase & Co | AddedHistory | 3,3533,337 | +16+0.5% | $1.08M$1.05M | +$5.15K | 1.0%1.0% | −0.06 |
| iShares Inc46434G509 | Added– | 60,16948,455 | +11,714+24.2% | $2.09M$1.63M | +$407.2K | 1.8%1.6% | +0.28 |
| NVDANVIDIA Corp | AddedHistory | 13,97613,975 | +10.0% | $2.61M$2.61M | +$186.53 | 2.3%2.5% | −0.21 |
| iShares Core S&P 500 ETF464287200 | Added– | 4,7074,046 | +661+16.3% | $3.22M$2.71M | +$452.7K | 2.8%2.6% | +0.24 |
| DBX ETF Tr233051200 | Added– | 127,851119,658 | +8,193+6.8% | $6.15M$5.55M | +$394.2K | 5.4%5.3% | +0.08 |
| Vanguard Ftse Developed Markets ETF921943858 | Added– | 123,208110,468 | +12,740+11.5% | $7.70M$6.62M | +$795.9K | 6.8%6.4% | +0.42 |
| iShares Core High Dividend ETF46429B663 | Added– | 69,30839,889 | +29,419+73.8% | $8.43M$4.88M | +$3.58M | 7.4%4.7% | +2.74 |
| Vanguard Ftse Emerging Markets ETF922042858 | Added– | 181,105136,722 | +44,383+32.5% | $9.74M$7.41M | +$2.39M | 8.6%7.1% | +1.46 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Added– | 50,64637,494 | +13,152+35.1% | $12.7M$9.62M | +$3.29M | 11.2%9.3% | +1.93 |
| iShares Inc46434G863 | Added– | 363,728197,985 | +165,743+83.7% | $16.1M$8.60M | +$7.32M | 14.2%8.3% | +5.90 |
| iShares Tr46435G516 | Added– | 211,190185,230 | +25,960+14.0% | $20.1M$17.2M | +$2.47M | 17.7%16.6% | +1.14 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.